Screening Versus Diagnostic Tests for COVID-19, What’s the Difference?
Screening determines whether an asymptomatic person is likely to have or develop disease, while diagnostics identify the cause of a patient’s illness - a crucial difference in the context of COVID-19.
Screening Versus Diagnostic Tests for COVID-19, What’s the Difference? Andrea Prinzi, Ph.D., MPH, SM(ASCP) Published: Dec. 7, 2020 Share This Save This During the COVID-19 pandemic, clinical testing has become a hot topic. The pandemic has required enormous effort on the part of both medicine and public health, but in the United States, the way these specialties function and use testing looks very different. Understanding the differences between tests in terms of their intended use and performance is imperative in achieving positive health outcomes for both the individual and the population as
Explore this link on the map →related reading
- Why don’t we screen healthy people to catch diseases early? | Out-Of-Pocketoutofpocket.health
- What Makes a Screening Exam "Good"? | Journal of Ethics | American Medical Associationjournalofethics.ama-assn.org
- Overview of the Pathogen Biosurveillance Landscape — EA Forumforum.effectivealtruism.org
- B.C. physicians’ Pap-a-palooza like a ‘golden ticket’ for patients - Healthy Debatehealthydebate.ca
- What Happens Next? COVID-19 Futures, Explained With Playable Simulationsncase.me
- How to Secure the DNA Supply Chain | IFPifp.org
- The Year the Pandemic “Ended” (Part III) – The New Inquirythenewinquiry.com
- Sensitivity and specificity - Wikipediaen.wikipedia.org
- Long COVID is devastating and far from rare. As infections rise again, why are we still ignoring it? - Salon.comsalon.com
- COVID-19 Wastewater Surveillance in Ontario | Public Health Ontariopublichealthontario.ca
- Scientists try to pinpoint why rapid Covid tests are missing some casesstatnews.com
- Inevitable Outbreaks: How to Stop an Age of Spillovers From Becoming an Age of Pandemicsforeignaffairs.com